ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen research firms that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month […]
More Stories
MetLife Investment Management LLC Acquires 13,460 Shares of FutureFuel Corp. (NYSE:FF)
MetLife Investment Management LLC grew its holdings in FutureFuel Corp. (NYSE:FF – Free Report) by 449.4% in the 4th quarter,...
MetLife Investment Management LLC Has $102,000 Stock Position in Beyond, Inc. (NYSE:BYON)
MetLife Investment Management LLC cut its stake in shares of Beyond, Inc. (NYSE:BYON – Free Report) by 19.1% in the...
First Trust Advisors LP Reduces Stock Position in Nature’s Sunshine Products, Inc. (NASDAQ:NATR)
First Trust Advisors LP cut its stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report) by 10.3% in the...
Criteo S.A. (NASDAQ:CRTO) Shares Bought by Stifel Financial Corp
Stifel Financial Corp lifted its holdings in shares of Criteo S.A. (NASDAQ:CRTO – Free Report) by 9.3% in the fourth...
Hsbc Holdings PLC Grows Stake in First Western Financial, Inc. (NASDAQ:MYFW)
Hsbc Holdings PLC increased its holdings in First Western Financial, Inc. (NASDAQ:MYFW – Free Report) by 5.0% during the fourth...
Hsbc Holdings PLC Sells 12,023 Shares of Hanmi Financial Co. (NASDAQ:HAFC)
Hsbc Holdings PLC cut its stake in shares of Hanmi Financial Co. (NASDAQ:HAFC – Free Report) by 50.4% in the...